Related Experiment Videos
Transient angle-closure glaucoma in central retinal vein occlusion
Summary
Transient angle-closure glaucoma associated with central retinal vein occlusion can be rapidly and permanently treated by deepening anterior chamber angles using cycloplegics and carbonic anhydrase inhibitors.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Retinal Vascular Diseases
Background:
- Angle-closure glaucoma can be a serious condition affecting vision.
- Central retinal vein occlusion (CRVO) is a significant vascular event in the eye.
- The co-occurrence of these conditions presents unique diagnostic and therapeutic challenges.
Purpose of the Study:
- To report two cases of unilateral transient angle-closure glaucoma (TACG) accompanying central retinal vein occlusion (CRVO).
- To describe the clinical presentation and treatment outcomes in these specific cases.
- To discuss the potential relationship between TACG, CRVO, and malignant glaucoma.
Main Methods:
- Case report of two patients presenting with unilateral TACG and CRVO.
- Ophthalmic examination including angle assessment and anterior segment imaging.
- Treatment with cycloplegics and carbonic anhydrase inhibitors.
Main Results:
- Both patients exhibited a marked anterior displacement of the lens-iris diaphragm in the affected eye.
- The uninvolved eye in both cases showed a wide-open anterior chamber angle.
- Short-term medical treatment led to rapid and permanent deepening of the anterior chamber angles.
Conclusions:
- Transient angle-closure glaucoma can occur concurrently with central retinal vein occlusion.
- Anterior displacement of the lens-iris diaphragm is a key feature in these cases.
- Medical management with cycloplegics and carbonic anhydrase inhibitors appears effective for angle deepening and potentially mitigating glaucoma progression in such scenarios.